Daniel W. Visscher

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.3K citations · Full text

Medicine, Cancer Biology, Oncology +14

Benign Breast Disease and the Risk of Breast Cancer

Lynn C. Hartmann, Thomas A. Sellers, Marlene H. Frost et al. · New England Journal of Medicine · 2005 · 942 citations · Full text

Medicine, Oncology, Pathology +17

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

Peter C. Brooks, Staffan Strömblad, Richard Klemke et al. · Journal of Clinical Investigation · 1995 · 831 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Matthew P. Goetz, James M. Rae, Vera J. Suman et al. · Journal of Clinical Oncology · 2005 · 786 citations · Full text

Medicine, Oncology, Pharmacology +16